Skip to main content
Premium Trial:

Request an Annual Quote

One (Peer Review Standard) for All …

National Science Foundation Director Subra Suresh has made international scientific collaborations a priority, but there has been one consistent challenge in getting researchers from the US and around the world to work with each other, says ScienceInsider's Jeffrey Mervis. It takes a lot of time to agree on rules regarding intellectual property, access to data, and — most importantly — standards for peer review, he adds. "We keep repeating the same thing over and over," Suresh tells Mervis. "Having to start from scratch causes considerable delay, and it is a big waste of time."

To solve this problem, Suresh has brought together 47 leaders of research funding agencies from 44 different countries to hammer out the first-ever global standards for peer review, Mervis says. In addition, the meeting is the official introduction of the Global Research Council. "The council intends to tackle a succession of problems affecting funding agencies around the world," Mervis adds.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.